首页 › 基金 › EcoR1 Capital, LLC › PHVS

EcoR1 Capital, LLC 对 PHVS 的持仓历史

PHARVARIS N V · 医疗保健

EcoR1 Capital, LLC 在 Q2 2026 的 13F 申报中披露持有 PHVS(PHARVARIS N V)235,000 股,市值约 US$8.1M,约占其申报组合的 0.42%,在其申报持仓中市值排名第 22 位。 EcoR1 Capital, LLC 最近 11 个申报季度中有 5 个季度披露了 PHVS 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q2 2026)235.00K 股
申报持仓市值$8.13M
组合权重0.42%
首次申报Q4 2023
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

EcoR1 Capital, LLC 对 PHVS 的持仓演变

EcoR1 Capital, LLC 于 Q4 2023 首次披露 PHVS 持仓:900,000 股(约 US$25.2M)。 在 5 次申报中,EcoR1 Capital, LLC 的持股数量始终未变。 最近一期申报(Q2 2026)显示持股 235,000 股、市值约 US$8.1M。

逐季持仓明细

季度股数金额变化
Q4 2023 900.00K $25.25M 新进
Q1 2024 900.00K $20.80M 持有
Q2 2024 900.00K $16.92M 持有
Q3 2024 900.00K $16.67M 持有
Q2 2026 235.00K $8.13M 新进

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PHVS 与 13F 数据

PHVS(PHARVARIS N V)属于医疗保健行业。我们追踪的基金中还有 49 只申报持有 PHVS,申报仓位最大的包括:GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PHVS 的基金

查看 PHVS 的全部基金持有人 →

常见问题

How long has EcoR1 Capital, LLC held PHVS?

EcoR1 Capital, LLC has disclosed PHVS holdings in 5 of the last 11 reported quarters, going back to Q4 2023.

What is EcoR1 Capital, LLC's current position in PHVS?

As of Q2 2026, EcoR1 Capital, LLC holds 235.00K shares of PHVS (PHARVARIS N V), valued at $8.13M, representing 0.42% of its reported portfolio and ranking #22.

Has EcoR1 Capital, LLC been buying or selling PHVS?

In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC newly opened its position in PHVS.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.